{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:42:59Z","timestamp":1788388979919,"version":"build-2803163510"},"reference-count":103,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["23-25-00174"],"award-info":[{"award-number":["23-25-00174"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>The activation of c-Jun N-terminal kinase (JNK) plays an important role in stroke outcomes. Tryptanthrin-6-oxime (TRYP-Ox) is reported to have high affinity for JNK and anti-inflammatory activity and may be of interest as a promising neuroprotective agent. The aim of this study was to investigate the neuroprotective effects of TRYP-Ox in a rat model of transient focal cerebral ischemia (FCI), which involved intraluminal occlusion of the left middle cerebral artery (MCA) for 1 h. Animals in the experimental group were administered intraperitoneal injections of TRYP-Ox 30 min before reperfusion and 23 and 47 h after FCI. Neurological status was assessed 4, 24, and 48 h following FCI onset. Treatment with 5 and 10 mg\/kg of TRYP-Ox decreased mean scores of neurological deficits by 35\u201349 and 46\u201367% at 24 and 48 h, respectively. At these doses, TRYP-Ox decreased the infarction size by 28\u201331% at 48 h after FCI. TRYP-Ox (10 mg\/kg) reduced the content of interleukin (IL) 1\u03b2 and tumor necrosis factor (TNF) in the ischemic core area of the MCA region by 33% and 38%, respectively, and attenuated cerebral edema by 11% in the left hemisphere, which was affected by infarction, and by 6% in the right, contralateral hemisphere 24 h after FCI. TRYP-Ox reduced c-Jun phosphorylation in the MCA pool at 1 h after reperfusion. TRYP-Ox was predicted to have high blood\u2013brain barrier permeability using various calculated descriptors and binary classification trees. Indeed, reactive oxidant production was significantly lower in the brain homogenates from rats treated with TRYP-Ox versus that in control animals. Our data suggest that the neuroprotective activity of TRYP-Ox may be due to the ability of this compound to inhibit JNK and exhibit anti-inflammatory and antioxidant activity. Thus, TRYP-Ox may be considered a promising neuroprotective agent that potentially could be used for the development of new treatment strategies in cerebral ischemia.<\/jats:p>","DOI":"10.3390\/ph16081057","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:45:02Z","timestamp":1690332302000},"page":"1057","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-6586","authenticated-orcid":false,"given":"Mark B.","family":"Plotnikov","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634028, Russia"},{"name":"Faculty of Radiophysics, National Research Tomsk State University, Tomsk 634050, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina A.","family":"Chernysheva","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634028, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera I.","family":"Smol\u2019yakova","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634028, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg I.","family":"Aliev","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634028, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Anishchenko","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634028, Russia"},{"name":"Department of Pharmacology, Siberian State Medical University, Tomsk 634050, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Ulyakhina","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634028, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene S.","family":"Trofimova","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634028, Russia"},{"name":"Department of Pharmacology, Siberian State Medical University, Tomsk 634050, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia A.","family":"Ligacheva","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634028, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1106-0730","authenticated-orcid":false,"given":"Nina D.","family":"Anfinogenova","sequence":"additional","affiliation":[{"name":"Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634012, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4763-3214","authenticated-orcid":false,"given":"Anton N.","family":"Osipenko","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Siberian State Medical University, Tomsk 634050, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9316-0964","authenticated-orcid":false,"given":"Anastasia R.","family":"Kovrizhina","sequence":"additional","affiliation":[{"name":"Kizhner Research Center, Tomsk Polytechnic University, Tomsk 634050, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3022-4510","authenticated-orcid":false,"given":"Andrei I.","family":"Khlebnikov","sequence":"additional","affiliation":[{"name":"Kizhner Research Center, Tomsk Polytechnic University, Tomsk 634050, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor A.","family":"Schepetkin","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0633-213X","authenticated-orcid":false,"given":"Anastasia G.","family":"Drozd","sequence":"additional","affiliation":[{"name":"Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Tomsk 634050, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4374-6422","authenticated-orcid":false,"given":"Evgenii V.","family":"Plotnikov","sequence":"additional","affiliation":[{"name":"Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Tomsk 634050, Russia"},{"name":"Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634014, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitriy N.","family":"Atochin","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8114-5073","authenticated-orcid":false,"given":"Mark T.","family":"Quinn","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1161\/STROKEAHA.113.001584","article-title":"Population-based study of disability and institutionalization after transient ischemic attack and stroke: 10-year results of the Oxford Vascular Study","volume":"44","author":"Paul","year":"2013","journal-title":"Stroke"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"E146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart Disease and Stroke Statistics-2017 Update A Report From the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/CIRCRESAHA.116.309278","article-title":"Acute Ischemic Stroke Therapy Overview","volume":"120","author":"Catanese","year":"2017","journal-title":"Circ. Res."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kuriakose, D., and Xiao, Z.C. (2020). Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207609"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/med.21817","article-title":"Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications","volume":"42","author":"Tuo","year":"2022","journal-title":"Med. Res. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Haupt, M., Gerner, S.T., B\u00e4hr, M., and Doeppner, T.R. (2023). Neuroprotective Strategies for Ischemic Stroke-Future Perspectives. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054334"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0038-1649503","article-title":"Global Burden of Stroke","volume":"38","author":"Katan","year":"2018","journal-title":"Semin. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1093\/brain\/awx126","article-title":"Neuroprotection in stroke: The importance of collaboration and reproducibility","volume":"140","author":"Neuhaus","year":"2017","journal-title":"Brain"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"119257","DOI":"10.1016\/j.lfs.2021.119257","article-title":"Neuroprotective effect of magnesium supplementation on cerebral ischemic diseases","volume":"272","author":"Xu","year":"2021","journal-title":"Life Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6687386","DOI":"10.1155\/2021\/6687386","article-title":"Neuroprotective phytochemicals in experimental ischemic stroke: Mechanisms and potential clinical applications","volume":"2021","author":"Xu","year":"2021","journal-title":"Oxidative Med. Cell. Long."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1161\/STROKEAHA.121.034947","article-title":"Top priorities for cerebroprotective studies-a paradigm shift report from STAIR XI","volume":"52","author":"Lyden","year":"2021","journal-title":"Stroke"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.STR.0000209330.73175.34","article-title":"Toward a multimodal neuroprotective treatment of stroke","volume":"37","author":"Rogalewski","year":"2006","journal-title":"Stroke"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1161\/STROKEAHA.110.592394","article-title":"New approaches to neuroprotective drug development","volume":"42","author":"Fisher","year":"2011","journal-title":"Stroke"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.04.010","article-title":"Citicoline for acute ischemic stroke: A systematic review and formal meta-analysis of randomized, double-blind, and placebo-controlled trials","volume":"25","author":"Secades","year":"2016","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/jnnp-2020-324283","article-title":"The future of neuroprotection in stroke","volume":"92","author":"Chamorro","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_16","first-page":"E2","article-title":"Experimental neuroprotection in ischemic stroke: A concise review","volume":"42","author":"Rajah","year":"2017","journal-title":"Neurosurg. Focus."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3940(00)01024-7","article-title":"c-Jun N-terminal kinase (JNK) and JNK interacting protein response in rat brain after transient middle cerebral artery occlusion","volume":"284","author":"Hayashi","year":"2000","journal-title":"Neurosci. Lett."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00004647-200206000-00001","article-title":"Role of mitogen- and stress-activated kinases in ischemic injury","volume":"22","author":"Irving","year":"2002","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00401-002-0661-2","article-title":"Early modifications in the expression of mitogen-activated protein kinase (MAPK\/ERK), stress-activated kinases SAPK\/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia","volume":"105","author":"Ferrer","year":"2003","journal-title":"Acta Neuropathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nm911","article-title":"A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia","volume":"9","author":"Borsello","year":"2003","journal-title":"Nat. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainres.2005.09.001","article-title":"Activation of c-Jun NH2-terminal kinase 3 is mediated by the GluR6 center dot PSD-95 center dot MLK3 signaling module following cerebral ischemia in rat hippocampus","volume":"1061","author":"Tian","year":"2005","journal-title":"Brain Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2016.02.033","article-title":"A novel dual NO-donating oxime and c-Jun N-terminal kinase inhibitor protects against cerebral ischemia-reperfusion injury in mice","volume":"618","author":"Atochin","year":"2016","journal-title":"Neurosci. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2174\/1389203721666200617133903","article-title":"An overview of stroke: Mechanism in vivo experimental models thereof, and neuroprotective agents","volume":"21","author":"Khan","year":"2020","journal-title":"Curr. Protein Pept. Sc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2174\/1871527319666200613223018","article-title":"MAPK: A Key Player in the development and progression of stroke","volume":"19","author":"Zheng","year":"2020","journal-title":"CNS Neurol. Disord-Dr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1124\/jpet.103.064246","article-title":"AS601245 (1,3-benzothiazol-2-yl(2-{[2-(3-pyridinyl)ethyl]amino}-4 pyrimidinyl) acetonitrile): A c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties","volume":"310","author":"Carboni","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/sj.jcbfm.9600062","article-title":"Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway","volume":"25","author":"Gao","year":"2005","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2006.03.086","article-title":"Neuroprotection against ischemic brain injury by SP600125 via suppressing the extrinsic and intrinsic pathways of apoptosis","volume":"1092","author":"Guan","year":"2006","journal-title":"Brain Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3389\/fphar.2018.00715","article-title":"c-Jun N-terminal kinases (JNKs) in myocardial and cerebral ischemia\/reperfusion injury","volume":"9","author":"Shvedova","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Rehfeldt, S.C.H., Laufer, S., and Goettert, M.I. (2021). A Highly selective in vitro JNK3 inhibitor, FMU200, restores mitochondrial membrane potential and reduces oxidative stress and apoptosis in SH-SY5Y cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073701"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Schepetkin, I.A., Chernysheva, G.A., Aliev, O.I., Kirpotina, L.N., Smol\u2019yakova, V.I., Osipenko, A.N., Plotnikov, M.B., Kovrizhina, A.R., Khlebnikov, A.I., and Plotnikov, E.V. (2022). Neuroprotective effects of the lithium salt of a novel JNK inhibitor in an animal model of cerebral ischemia-reperfusion. Biomedicines, 10.","DOI":"10.3390\/biomedicines10092119"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Plotnikov, M.B., Chernysheva, G.A., Smolyakova, V.I., Aliev, O.I., Trofimova, E.S., Sherstoboev, E.Y., Osipenko, A.N., Khlebnikov, A.I., Anfinogenova, Y.J., and Schepetkin, I.A. (2020). neuroprotective effects of a novel inhibitor of c-Jun N-terminal kinase in the rat model of transient focal cerebral ischemia. Cells, 9.","DOI":"10.3390\/cells9081860"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Plotnikov, M.B., Chernysheva, G.A., Aliev, O.I., Smol\u2019iakova, V.I., Fomina, T.I., Osipenko, A.N., Rydchenko, V.S., Anfinogenova, Y.J., Khlebnikov, A.I., and Schepetkin, I.A. (2019). Protective effects of a new c-Jun N-terminal kinase inhibitor in the model of global cerebral ischemia in rats. Molecules, 24.","DOI":"10.3390\/molecules24091722"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.clineuro.2009.04.001","article-title":"The complexity of neurobiological processes in acute ischemic stroke","volume":"111","author":"Brouns","year":"2009","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S1474-4422(16)00114-9","article-title":"Neuroprotection in acute stroke: Targeting excitotoxicity, oxidative and nitrosative stress, and inflammation","volume":"15","author":"Chamorro","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"104877","DOI":"10.1016\/j.phrs.2020.104877","article-title":"Therapeutic targets of oxidative\/nitrosative stress and neuroinflammation in ischemic stroke: Applications for natural product efficacy with omics and systemic biology","volume":"158","author":"Chen","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s13311-016-0483-x","article-title":"Inflammation and Stroke: An Overview","volume":"13","author":"Anrather","year":"2016","journal-title":"Neurotherapeutics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"113518","DOI":"10.1016\/j.expneurol.2020.113518","article-title":"Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies","volume":"335","author":"Paul","year":"2021","journal-title":"Exp. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1016\/j.bmc.2017.07.003","article-title":"Recent synthetic and medicinal perspectives of tryptanthrin","volume":"25","author":"Kaur","year":"2017","journal-title":"Bioorgan Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3389\/fphar.2020.01145","article-title":"Therapeutic effects of tryptanthrin and tryptanthrin-6-oxime in models of rheumatoid arthritis","volume":"11","author":"Kirpotina","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1055\/s-0042-105295","article-title":"Pharmacokinetics and in vitro blood-brain barrier screening of the plant-derived alkaloid tryptanthrin","volume":"82","author":"Jahne","year":"2016","journal-title":"Planta Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejmech.2018.10.023","article-title":"Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors","volume":"161","author":"Schepetkin","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"10429","DOI":"10.3390\/molecules170910429","article-title":"Computational Prediction of Blood-Brain Barrier Permeability Using Decision Tree Induction","volume":"17","author":"Suenderhauf","year":"2012","journal-title":"Molecules"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0748-5514(86)90125-X","article-title":"Visible chemiluminescence from rat brain homogenates undergoing autoxidation. I. Effect of additives and products accumulation","volume":"2","author":"Lissi","year":"1986","journal-title":"J. Free Radic. Biol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/bj2630273","article-title":"Brain chemiluminescence and oxidative stress in hyperthyroid rats","volume":"263","author":"Adamo","year":"1989","journal-title":"Biochem. J."},{"key":"ref_45","first-page":"741","article-title":"Importance of two iron-reducing systems in lipid peroxidation of rat brain: Implications for oxygen toxicity in the central nervous system","volume":"14","author":"Arai","year":"1987","journal-title":"Biochem. Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0891-5849(95)00100-C","article-title":"Effect of tert-butyl hydroperoxide addition on spontaneous chemiluminescence in brain","volume":"19","author":"Azorin","year":"1995","journal-title":"Free Radic. Biol. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1014004414733","article-title":"Stimulation of lipid peroxidation in vitro in rat brain by the metabolites accumulating in maple syrup urine disease","volume":"17","author":"Fontella","year":"2002","journal-title":"Metab. Brain Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11011-009-9136-7","article-title":"Effects of 1,4-butanediol administration on oxidative stress in rat brain: Study of the neurotoxicity of gamma-hydroxybutyric acid in vivo","volume":"24","author":"Sgaravatti","year":"2009","journal-title":"Metab. Brain Dis."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Yeh, C.Y., Schulien, A.J., Molyneaux, B.J., and Aizenman, E. (2020). Lessons from recent advances in ischemic stroke management and targeting Kv2.1 for neuroprotection. Int. J. Mol. Sci., 21.","DOI":"10.20944\/preprints202008.0094.v1"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1016\/j.bmc.2010.06.090","article-title":"Lipophilic phenolic antioxidants: Correlation between antioxidant profile, partition coefficients and redox properties","volume":"18","author":"Roleira","year":"2010","journal-title":"Bioorgan Med. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.addr.2021.01.015","article-title":"Targeting the blood-brain barrier for the delivery of stroke therapies","volume":"171","author":"Dave","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/bc.bc_58_19","article-title":"Multiphase adjuvant neuroprotection: A novel paradigm for improving acute ischemic stroke outcomes","volume":"6","author":"Zhao","year":"2020","journal-title":"Brain Circ."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbr.2010.06.026","article-title":"Acute, post-ischemic sensorimotor deficits correlate positively with infarct size but fail to predict its occurrence and magnitude after middle cerebral artery occlusion in rats","volume":"216","author":"Senda","year":"2011","journal-title":"Behav. Brain Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.expneurol.2014.02.005","article-title":"Severity of middle cerebral artery occlusion determines retinal deficits in rats","volume":"254","author":"Allen","year":"2014","journal-title":"Exp. Neurol."},{"key":"ref_55","first-page":"R103","article-title":"High-soy diet decreases infarct size after permanent middle cerebral artery occlusion in female rats","volume":"289","author":"Schreihofer","year":"2005","journal-title":"Am. J. Physiol.-Reg."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/01.STR.23.2.267","article-title":"Neurological and Behavioral Outcomes of Focal Cerebral-Ischemia in Rats","volume":"23","author":"Wahl","year":"1992","journal-title":"Stroke"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0361-9230(02)00962-0","article-title":"Examination of sensorimotor performance following middle cerebral artery occlusion in rats","volume":"59","author":"Reglodi","year":"2003","journal-title":"Brain Res. Bull."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.steroids.2016.07.006","article-title":"Diosgenin attenuates the brain injury induced by transient focal cerebral ischemia-reperfusion in rats","volume":"113","author":"Zhang","year":"2016","journal-title":"Steroids"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-8993(00)03228-5","article-title":"SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia","volume":"892","author":"Legos","year":"2001","journal-title":"Brain Res"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbr.2011.03.019","article-title":"Morphological and neuro-behavioral parallels in the rat model of stroke","volume":"223","author":"Boyko","year":"2011","journal-title":"Behav. Brain Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1568007053005145","article-title":"Targeting the JNK signaling pathway for stroke and Parkinson\u2019s diseases therapy","volume":"4","author":"Kuan","year":"2005","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainresrev.2006.11.003","article-title":"Molecular targets in cerebral ischemia for developing novel therapeutics","volume":"54","author":"Mehta","year":"2007","journal-title":"Brain Res. Rev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1460-9568.2005.03857.x","article-title":"Specific pathophysiological functions of JNK isoforms in the brain","volume":"21","author":"Brecht","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1002\/j.1460-2075.1996.tb00636.x","article-title":"Selective interaction of JNK protein kinase isoforms with transcription factors","volume":"15","author":"Gupta","year":"1996","journal-title":"EMBO J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"459265","DOI":"10.1155\/2012\/459265","article-title":"Diverse roles of JNK and MKK pathways in the brain","volume":"2012","author":"Yamasaki","year":"2012","journal-title":"J. Signal Transduct."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"15184","DOI":"10.1073\/pnas.2336254100","article-title":"A critical role of neural-specific JNK3 for ischemic apoptosis","volume":"100","author":"Kuan","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1124\/mol.111.077446","article-title":"Identification and characterization of a novel class of c-Jun N-terminal kinase inhibitors","volume":"81","author":"Schepetkin","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuroscience.2004.09.031","article-title":"The neuroprotective effects of K252a through inhibiting MLK3\/MKK7\/JNK3 signaling pathway on ischemic brain injury in rat hippocampal CA1 region","volume":"131","author":"Pan","year":"2005","journal-title":"Neuroscience"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.bjp.0707574","article-title":"AS601245, a c-Jun NH2-terminal kinase (JNK) inhibitor, reduces axon\/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils","volume":"153","author":"Carboni","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.bmcl.2011.12.028","article-title":"Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury","volume":"22","author":"Krenitsky","year":"2012","journal-title":"Bioorg Med. Chem. Lett."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1517\/13543776.2015.1039984","article-title":"c-Jun N-terminal kinase inhibitors: A patent review (2010\u20132014)","volume":"25","author":"Gehringer","year":"2015","journal-title":"Expert. Opin. Ther. Pat."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1021\/jm501212r","article-title":"Inhibitors of c-Jun N-terminal kinases: An update","volume":"58","author":"Koch","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1471-4159.2008.05797.x","article-title":"Limited role of the c-Jun N-terminal kinase pathway in a neonatal rat model of cerebral hypoxia-ischemia","volume":"108","author":"Ginet","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s12975-020-00806-z","article-title":"Cell death pathways in ischemic stroke and targeted pharmacotherapy","volume":"11","author":"Datta","year":"2020","journal-title":"Trans. Stroke Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10571-013-9939-2","article-title":"Xanthotoxol Exerts Neuroprotective Effects Via Suppression of the inflammatory response in a rat model of focal cerebral ischemia","volume":"33","author":"He","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Hammouda, M.B., Ford, A.E., Liu, Y., and Zhang, J.Y. (2020). The JNK signaling pathway in inflammatory skin disorders and cancer. Cells, 9.","DOI":"10.3390\/cells9040857"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pneurobio.2006.03.006","article-title":"Role of the AP-1 transcription factor c-Jun in developing, adult and injured brain","volume":"78","author":"Raivich","year":"2006","journal-title":"Prog. Neurobiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bbi.2020.09.025","article-title":"Filling the gaps on stroke research: Focus on inflammation and immunity","volume":"91","author":"Levard","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(03)00255-9","article-title":"Inflammatory gene expression in focal cortical brain ischemia: Differences between rats and mice","volume":"117","author":"Schroeter","year":"2003","journal-title":"Mol. Brain Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"107695","DOI":"10.1016\/j.pharmthera.2020.107695","article-title":"Natural medicine in neuroprotection for ischemic stroke: Challenges and prospective","volume":"216","author":"Tao","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.freeradbiomed.2005.05.003","article-title":"Antioxidant strategies in the treatment of stroke","volume":"39","author":"Margaill","year":"2005","journal-title":"Free Radic. Bio Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2165\/00002512-200724070-00002","article-title":"Neuroprotective effects of free radical scavengers in stroke","volume":"24","author":"Wang","year":"2007","journal-title":"Drug Aging"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0028-3908(01)00019-3","article-title":"Oxidative stress induced-neurodegenerative diseases: The need for antioxidants that penetrate the blood brain barrier","volume":"40","author":"Melamed","year":"2001","journal-title":"Neuropharmacology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1568007053544156","article-title":"Free radical trapping as a therapeutic approach to neuroprotection in stroke: Experimental and clinical studies with NXY-059 and free radical scavengers","volume":"4","author":"Green","year":"2005","journal-title":"CNS Neurol. Disord-Dr."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/STROKEAHA.118.023815","article-title":"Clinical effects of early edaravone use in acute ischemic stroke patients treated by endovascular reperfusion therapy","volume":"50","author":"Enomoto","year":"2019","journal-title":"Stroke"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2174\/092986708783497337","article-title":"Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging","volume":"15","author":"Slemmer","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.freeradbiomed.2009.02.027","article-title":"Protection by tetrahydroxystilbene glucoside against cerebral ischemia: Involvement of JNK, SIRT1, and NF-kappa B pathways and inhibition of intracellular ROS\/RNS generation","volume":"47","author":"Wang","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"44326","DOI":"10.1074\/jbc.M111.283481","article-title":"Glucocorticoids and tumor necrosis factor \u03b1 increase oxidative stress and suppress wnt protein signaling in osteoblasts","volume":"286","author":"Almeida","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1074\/jbc.M207391200","article-title":"A single c-Jun N-terminal kinase isoform (JNK3-p54) is an effector in both neuronal differentiation and cell death","volume":"278","author":"Waetzig","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neulet.2006.07.007","article-title":"Antioxidant N-acetylcysteine inhibits the activation of JNK3 mediated by the GluR6-PSD95-MLK3 signaling module during cerebral ischemia in rat hippocampus","volume":"408","author":"Zhang","year":"2006","journal-title":"Neurosci. Lett."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.neuroscience.2010.02.018","article-title":"Neuroprotection of ethanol against ischemia\/reperfusion-induced brain injury through decreasing c-Jun N-terminal kinase 3 (JNK3) activation by enhancing GABA release","volume":"167","author":"Qi","year":"2010","journal-title":"Neuroscience"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/S0960-894X(02)00431-6","article-title":"Novel indolo[2,1-b]quinazoline analogues as cytostatic agents: Synthesis, biological evaluation and structure-activity relationship","volume":"12","author":"Sharma","year":"2002","journal-title":"Bioorg Med. Chem. Lett."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1161\/STROKEAHA.108.541128","article-title":"Update of the stroke therapy academic industry roundtable preclinical recommendations","volume":"40","author":"Fisher","year":"2009","journal-title":"Stroke"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic. Clin. Pharm."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1021\/ci00053a005","article-title":"Atomic physicochemical parameters for 3-dimensional-structure-directed quantitative structure-activity-relationships. 2. Modeling dispersive and hydrophobic interactions","volume":"27","author":"Ghose","year":"1987","journal-title":"J. Chem. Inf. Comp. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","article-title":"Reversible middle cerebral-artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1177\/0271678X17709185","article-title":"The IMPROVE guidelines (ischaemia models: Procedural refinements of in vivo experiments)","volume":"37","author":"Alfieri","year":"2017","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/01.STR.32.4.1005","article-title":"Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats","volume":"32","author":"Chen","year":"2001","journal-title":"Stroke"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.STR.22.8.1032","article-title":"Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral-ischemia","volume":"22","author":"Kaplan","year":"1991","journal-title":"Stroke"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3389\/fnins.2019.01105","article-title":"A novel method for assessing cerebral edema, infarcted zone and blood-brain barrier breakdown in a single post-stroke rodent brain","volume":"13","author":"Kuts","year":"2019","journal-title":"Front. Neurosci-Switz."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1161\/01.STR.0000032302.91894.0F","article-title":"Behavioral tests after intracerebral hemorrhage in the rat","volume":"33","author":"Hua","year":"2002","journal-title":"Stroke"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12975-012-0152-2","article-title":"Brain water content. A misunderstood measurement?","volume":"3","author":"Keep","year":"2012","journal-title":"Transl. Stroke Res."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/16\/8\/1057\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:18:42Z","timestamp":1760127522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/16\/8\/1057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":103,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["ph16081057"],"URL":"https:\/\/doi.org\/10.3390\/ph16081057","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,25]]}}}